Siponimod May Improve Thinking Skills in Advanced Multiple Sclerosis: Study Hina Zahid17 Dec 2020 9:15 AM GMTMINNEAPOLIS - Researchers have found in a new study that people with the advanced form of multiple sclerosis (MS) called secondary progressive MS who...
Multiple sclerosis may not increase risk for breast, colorectal cancers: Study Hina Zahid27 Nov 2020 11:00 AM GMTMINNEAPOLIS - People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur most commonly in people...
High-dose biotin does not significantly improve multiple sclerosis: Lancet Medha3 Nov 2020 12:28 PM GMTUSA: The use of MD1003, a high-dose of pharmaceutical-grade biotin, did not help in significant improvement of walking speed or disability in patients ...
Beetroot peptide as potential drug candidate for treating inflammatory diseases Hina Zahid1 Nov 2020 11:15 AM GMTIn a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule)...
Zydus Cadila gets USFDA okay for Fingolimod Capsules, Verapamil Hydrochloride Injection ruchika17 Oct 2020 5:46 AM GMTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fingolimod...
A Simple sugar may promote myelin repair in multiple sclerosis: Study Hina Zahid11 Oct 2020 12:15 PM GMTIrvine, CA- Myelination plays an important role in cognitive development and in demyelinating diseases like multiple sclerosis (MS), where failure of...
Lupin gets USFDA nod to generic equivalent of Tecfidera Delayed-Release Capsules ruchika7 Oct 2020 7:01 AM GMTMumbai, Baltimore: Pharma major, Lupin Limited, has recently announced that the company has received approval for its Dimethyl Fumarate Delayed-Releas...
Dr Reddys unveils multiple sclerosis drug Dimethyl Fumarate Delayed-Release Capsules ruchika28 Sep 2020 10:00 AM GMTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic ...
Cipla gets USFDA nod for Dimethyl Fumarate DR Capsules to treat multiple sclerosis ruchika27 Sep 2020 4:30 AM GMTMumbai: Drugmaker, Cipla Limited, has recently announced that the company has received final approval for its Abbreviated New Drug Application (A...
Zydus Cadila gets USFDA nod for multiple sclerosis drug ruchika26 Sep 2020 4:30 AM GMTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the U.S. Food and Drug Administration...
Adolescent obesity and smoking linked to Multiple sclerosis risk: study Dr Satabdi Saha8 Sep 2020 12:30 PM GMTAccording to a recent research report, teen and adolescent obesity and other lifestyle habits such as smoking may affect the chances of developing...
Mylan launches generic Tecfidera for treatment of Multiple Sclerosis ruchika21 Aug 2020 8:02 AM GMTHertfordshire and Pittsburgh: Mylan N.V. has announced the launch of the first FDA-approved therapeutically equivalent, substi...
